161 related articles for article (PubMed ID: 20098508)
21. Ascorbic Acid Sensitizes Colorectal Carcinoma to the Cytotoxicity of Arsenic Trioxide
Tian W; Wang Z; Tang NN; Li JT; Liu Y; Chu WF; Yang BF
Front Pharmacol; 2020; 11():123. PubMed ID: 32153415
[TBL] [Abstract][Full Text] [Related]
22. Chlorogenic acid induced apoptosis and inhibition of proliferation in human acute promyelocytic leukemia HL‑60 cells.
Liu YJ; Zhou CY; Qiu CH; Lu XM; Wang YT
Mol Med Rep; 2013 Oct; 8(4):1106-10. PubMed ID: 23982123
[TBL] [Abstract][Full Text] [Related]
23.
Yedjou CG; Sims JN; Njiki S; Tsabang N; Ogungbe IV; Tchounwou PB
Glob J Adv Eng Technol Sci; 2018 Aug; 5(8):1-9. PubMed ID: 30310827
[TBL] [Abstract][Full Text] [Related]
24. Transcriptomic analysis of the PI3K/Akt signaling pathway reveals the dual role of the c-Jun oncogene in cytotoxicity and the development of resistance in HL-60 leukemia cells in response to arsenic trioxide.
Roszak J; Smok-Pieniążek A; Stępnik M
Adv Clin Exp Med; 2017 Dec; 26(9):1335-1342. PubMed ID: 29442453
[TBL] [Abstract][Full Text] [Related]
25. JNK activation is a mediator of arsenic trioxide-induced apoptosis in acute promyelocytic leukemia cells.
Davison K; Mann KK; Waxman S; Miller WH
Blood; 2004 May; 103(9):3496-502. PubMed ID: 14701702
[TBL] [Abstract][Full Text] [Related]
26. Basic apoptotic mechanisms of lead toxicity in human leukemia (HL-60) cells.
Yedjou CG; Milner JN; Howard CB; Tchounwou PB
Int J Environ Res Public Health; 2010 May; 7(5):2008-17. PubMed ID: 20623007
[TBL] [Abstract][Full Text] [Related]
27. Ascorbic acid enhances arsenic trioxide-induced cytotoxicity in multiple myeloma cells.
Grad JM; Bahlis NJ; Reis I; Oshiro MM; Dalton WS; Boise LH
Blood; 2001 Aug; 98(3):805-13. PubMed ID: 11468182
[TBL] [Abstract][Full Text] [Related]
28. Trolox selectively enhances arsenic-mediated oxidative stress and apoptosis in APL and other malignant cell lines.
Diaz Z; Colombo M; Mann KK; Su H; Smith KN; Bohle DS; Schipper HM; Miller WH
Blood; 2005 Feb; 105(3):1237-45. PubMed ID: 15466933
[TBL] [Abstract][Full Text] [Related]
29. Adding ascorbic acid to arsenic trioxide produces limited benefit in patients with acute myeloid leukemia excluding acute promyelocytic leukemia.
Aldoss I; Mark L; Vrona J; Ramezani L; Weitz I; Mohrbacher AM; Douer D
Ann Hematol; 2014 Nov; 93(11):1839-43. PubMed ID: 24906216
[TBL] [Abstract][Full Text] [Related]
30. Antileukemic effect of paclitaxel in combination with metformin in HL-60 cell line.
Asik A; Kayabasi C; Ozmen Yelken B; Yılmaz Susluer S; Dogan Sigva ZO; Balcı Okcanoglu T; Saydam G; Biray Avci C; Gunduz C
Gene; 2018 Mar; 647():213-220. PubMed ID: 29309887
[TBL] [Abstract][Full Text] [Related]
31. Melatonin enhances arsenic trioxide-induced cytotoxicity by modulating autophagy in an acute promyelocytic leukemia cell line.
Wei X; Pu X; Yang S; Meng X; Chen X; Zhang Z; Sheng X; Xiang D; Zhang Y
Transl Cancer Res; 2019 Sep; 8(5):2079-2088. PubMed ID: 35116957
[TBL] [Abstract][Full Text] [Related]
32. Malignant cells can be sensitized to undergo growth inhibition and apoptosis by arsenic trioxide through modulation of the glutathione redox system.
Dai J; Weinberg RS; Waxman S; Jing Y
Blood; 1999 Jan; 93(1):268-77. PubMed ID: 9864170
[TBL] [Abstract][Full Text] [Related]
33. New retinoids and arsenic compounds for the treatment of refractory acute promyelocytic leukemia: clinical and basic studies for the next generation.
Kitamura K; Kiyoi H; Yoshida H; Tobita T; Takeshita A; Ohno R; Naoe T
Cancer Chemother Pharmacol; 1997; 40 Suppl():S36-41. PubMed ID: 9272132
[TBL] [Abstract][Full Text] [Related]
34. Fucoidan enhances the therapeutic potential of arsenic trioxide and all-trans retinoic acid in acute promyelocytic leukemia, in vitro and in vivo.
Atashrazm F; Lowenthal RM; Dickinson JL; Holloway AF; Woods GM
Oncotarget; 2016 Jul; 7(29):46028-46041. PubMed ID: 27329592
[TBL] [Abstract][Full Text] [Related]
35. Apoptosis induction in human leukemic promyelocytic HL-60 and monocytic U937 cell lines by goniothalamin.
Petsophonsakul P; Pompimon W; Banjerdpongchai R
Asian Pac J Cancer Prev; 2013; 14(5):2885-9. PubMed ID: 23803048
[TBL] [Abstract][Full Text] [Related]
36. Arsenic trioxide inhibits neuroblastoma growth in vivo and promotes apoptotic cell death in vitro.
Ora I; Bondesson L; Jönsson C; Ljungberg J; Pörn-Ares I; Garwicz S; Pâhlman S
Biochem Biophys Res Commun; 2000 Oct; 277(1):179-85. PubMed ID: 11027660
[TBL] [Abstract][Full Text] [Related]
37. G-CSF upregulates the expression of aquaporin-9 through CEBPB to enhance the cytotoxic activity of arsenic trioxide to acute myeloid leukemia cells.
Fu W; Zhu G; Xu L; Liu J; Han X; Wang J; Wang X; Hou J; Zhao H; Zhong H
Cancer Cell Int; 2022 May; 22(1):195. PubMed ID: 35590355
[TBL] [Abstract][Full Text] [Related]
38. Synergic effects of arsenic trioxide and cAMP during acute promyelocytic leukemia cell maturation subtends a novel signaling cross-talk.
Zhu Q; Zhang JW; Zhu HQ; Shen YL; Flexor M; Jia PM; Yu Y; Cai X; Waxman S; Lanotte M; Chen SJ; Chen Z; Tong JH
Blood; 2002 Feb; 99(3):1014-22. PubMed ID: 11807007
[TBL] [Abstract][Full Text] [Related]
39. Arsenic trioxide induces apoptosis in cells of MOLT-4 and its daunorubicin-resistant cell line via depletion of intracellular glutathione, disruption of mitochondrial membrane potential and activation of caspase-3.
Hu XM; Hirano T; Oka K
Cancer Chemother Pharmacol; 2003 Jul; 52(1):47-58. PubMed ID: 12750841
[TBL] [Abstract][Full Text] [Related]
40. Arsenic trioxide as an inducer of apoptosis and loss of PML/RAR alpha protein in acute promyelocytic leukemia cells.
Shao W; Fanelli M; Ferrara FF; Riccioni R; Rosenauer A; Davison K; Lamph WW; Waxman S; Pelicci PG; Lo Coco F; Avvisati G; Testa U; Peschle C; Gambacorti-Passerini C; Nervi C; Miller WH
J Natl Cancer Inst; 1998 Jan; 90(2):124-33. PubMed ID: 9450572
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
